SCHEMBL1968089

SCHEMBL1968089

CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
HRH1 P35367 4/20 0.69
DRD3 P35462 4/20 0.69
KCNH2 Q12809 4/20 0.69
HTR2A P28223 3/20 0.69
HTR2B P41595 3/20 0.69
BLM P54132 2/20 0.69
CNR1 P21554 1/20 0.69
APEX1 P27695 1/20 0.69
PDE4A P27815 1/20 0.69
PDE3A Q14432 1/20 0.69
DRD2 P14416 3/20 0.68
ALOX15 P16050 1/20 0.68
HSD17B10 Q99714 1/20 0.68
SLC6A4 P31645 4/20 0.62
SLC6A3 Q01959 4/20 0.62
SLC6A2 P23975 3/20 0.62
NPC1 O15118 2/20 0.62
EGFR P00533 2/20 0.62
FYN P06241 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12021980 0.93 LMNA (0.62) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL12142463 0.91 LMNA (0.59) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL8811661 0.90 LMNA (0.59) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL6385060 0.90 KCNH2 (0.70) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL10762463 0.90 KCNH2 (0.70) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL1968825 0.90 LMNA (0.58) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL1968701 0.87 LMNA (0.57) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL11010415 0.87 KCNH2 (0.58) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL1969921 0.86 BCHE (0.61) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL10766174 0.86 BCHE (0.62) LMNAHRH1DRD3KCNH2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476445-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2013-07-02 US disclosed
US-8476445-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2013-07-02 US disclosed
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2011-12-01 US disclosed
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2011-12-01 US disclosed
US-8022220-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-09-20 US disclosed
US-8022220-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-09-20 US disclosed
EP-1958935-B1 Process for the production of terfenadine and carebastine derivatives with microorganisms ALBANY MOLECULAR RES INC (US) 2011-06-22 EP disclosed
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed
US-7691615-B2 Process for the production of piperidine derivatives with microorganisms ALBANY MOLECULAR RESEARCH, INC. (US) 2010-04-06 US disclosed
US-20020087003-A1 Process for the production of piperidine derivatives with microorganisms APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT 2002-07-04 US disclosed
US-6201124-B1 CONVERTING, WITH A PIPERIDINE COMPOUND, REGIOISOMERS UNDER NON-FRIEDEL-CRAFTS REACTION CONDITIONS ALBANY MOLECULAR RESEARCH, INC. 2001-03-13 US disclosed
US-6153754-A Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2000-11-28 US disclosed
EP-0868182-A4 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RES INC (US) 1999-04-07 EP disclosed
EP-0877733-A4 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RES INC (US) 1999-03-31 EP disclosed
EP-0877733-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1998-11-18 EP disclosed
EP-0868182-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1998-10-07 EP disclosed
WO-1997023213-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1997-07-03 WO disclosed
WO-1997022344-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1997-06-26 WO disclosed
WO-1997009983-A1 PIPERIDINE DERIVATIVES AND PROCESSES FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1997-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES OR10J3, NR1H2, NR1H3 LMNA 4284/4885HRH1 313/4885DRD3 448/4885
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES HPD, PTMA, HAAO LMNA 2264/4885HRH1 727/4885DRD3 687/4885
US-20020087003-A1 Process for the production of piperidine derivatives with microorganisms CBR1, CBR3, DRD4 LMNA 4093/4885HRH1 46/4885DRD3 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.